US Patent Issued to CHANGCHUN BCHT BIOTECHNOLOGY, JILIN UNIVERSITY on Sept. 16 for "Phosphorylated polypeptide antigen vaccine, preparation method therefor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,987, issued on Sept. 16, was assigned to CHANGCHUN BCHT BIOTECHNOLOGY Co. (Changchun, China) and JILIN UNIVERSITY (Changchun, China).

"Phosphorylated polypeptide antigen vaccine, preparation method therefor and application thereof" was invented by Wei Kong (Changchun, China), Hui Wu (Changchun, China), Yao Sun (Changchun, China) and Yongqing Guo (Changchun, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a phosphorylated polypeptide antigen vaccine, comprising at least two polypeptide fragments or conservatively modified variants thereof from human full-length Tau protein, wherein the polypeptide fragments or co...